drugset / Trial / NCT00935415
Time-Effect of Montelukast Protection
RandomizedCrossoverDouble-blindTreatment
Summary
The aim of this study is to verify MNT time of onset of protection against EIB in asthmatic children by evaluating different time intervals between dosing and challenge, after a single-dose and after three days of once a day MNT administration.
Timeline
- Start
- 2007-01
- Primary completion
- 2008-08
- Completion
- 2008-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Montelukast | Other / unclassified | 5 mg | — |